Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Muhammad Aetesam Ur-Rahman"'
Autor:
Hirofumi Ohashi, Damien Collison, Takuya Mizukami, Matthaios Didagelos, Koshiro Sakai, Muhammad Aetesam-ur-Rahman, Daniel Munhoz, Peter McCartney, Thomas J. Ford, Mitchell Lindsay, Aadil Shaukat, Paul Rocchiccioli, Richard Brogan, Stuart Watkins, Margaret McEntegart, Richard Good, Keith Robertson, Patrick O’Boyle, Andrew Davie, Adnan Khan, Stuart Hood, Hany Eteiba, Tetsuya Amano, Jeroen Sonck, Colin Berry, Bernard De Bruyne, Keith G. Oldroyd, Carlos Collet
Publikováno v:
Diagnostics, Vol 13, Iss 15, p 2612 (2023)
Assessing coronary physiology after stent implantation facilitates the optimisation of percutaneous coronary intervention (PCI). Coronary artery disease (CAD) patterns can be characterised by the pullback pressure gradient (PPG) index. The impact of
Externí odkaz:
https://doaj.org/article/430bc3e26bca4b33ab75dbc555874a79
Autor:
Muhammad Aetesam-ur-Rahman, Joel P. Giblett, Bharat Khialani, Stephen Kyranis, Sophie J. Clarke, Tian X. Zhao, Denise M. Braganza, Sarah C. Clarke, Nick E. J. West, Martin R. Bennett, Stephen P. Hoole
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Incretin therapies appear to provide cardioprotection and improve cardiovascular outcomes in patients with diabetes, but the mechanism of this effect remains elusive. We have previously shown that glucagon-like peptide (GLP)-1 is
Externí odkaz:
https://doaj.org/article/d286fb542d1246fc8a722b0a04ccca0b
Autor:
Muhammad Aetesam‐ur‐Rahman, Tian X. Zhao, Kitty Paques, Joana Oliveira, Bharat Khialani, Stephen Kyranis, Denise M. Braganza, Sarah C. Clarke, Martin R. Bennett, Nick E. J. West, Stephen P. Hoole
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 9 (2022)
Background Post–percutaneous coronary intervention (PCI) fractional flow reserve ≥0.90 is an accepted marker of procedural success, and a cutoff of ≥0.95 has recently been proposed for post‐PCI instantaneous wave‐free ratio. However, stabil
Externí odkaz:
https://doaj.org/article/511ad4b921144eb2af6456dc040dda07
Autor:
Muhammad Aetesam‐ur‐Rahman, Adam J. Brown, Catherine Jaworski, Joel P. Giblett, Tian X. Zhao, Denise M. Braganza, Sarah C. Clarke, Bobby S. K. Agrawal, Martin R. Bennett, Nick E. J. West, Stephen P. Hoole
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 13 (2021)
Background Adenosine is used to treat no‐reflow in the infarct‐related artery (IRA) during ST‐segment–elevation myocardial infarction intervention. However, the physiological effect of adenosine in the IRA is variable. Coronary steal—a redu
Externí odkaz:
https://doaj.org/article/a277b79727b44ff2b4e9731824378745
Autor:
Sophie J. Clarke, Joel P. Giblett, Lucy L. Yang, Annette Hubsch, Tian Zhao, Muhammad Aetesam‐ur‐Rahman, Nick E. J. West, Michael O'Sullivan, Nichola Figg, Martin Bennett, Nicolai J. Wewer Albrechtsen, Carolyn F. Deacon, Joseph Cheriyan, Stephen P. Hoole
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 22 (2018)
Background The mechanism underlying the beneficial cardiovascular effects of the incretin GLP‐1 (glucagon‐like peptide 1) and its analogues in humans is elusive. We hypothesized that activating receptors located on vascular smooth muscle cells to
Externí odkaz:
https://doaj.org/article/255ac1c5a2b842a7b3952e71d4047f13
Autor:
Damien Collison, Samuel Copt, Takuya Mizukami, Carlos Collet, Ruth McLaren, Matthaios Didagelos, Muhammad Aetesam-ur-Rahman, Peter McCartney, Thomas J. Ford, Mitchell Lindsay, Aadil Shaukat, Paul Rocchiccioli, Richard Brogan, Stuart Watkins, Margaret McEntegart, Richard Good, Keith Robertson, Patrick O’Boyle, Andrew Davie, Adnan Khan, Stuart Hood, Hany Eteiba, Colin Berry, Keith G. Oldroyd
Publikováno v:
Circulation: Cardiovascular Interventions. 16
Background: Twenty percent to 40% of patients are affected by angina after percutaneous coronary intervention (PCI), which is associated with anxiety, depression, impaired physical function, and reduced quality of life. Understanding patient and proc
Autor:
Damien Collison, Samuel Copt, Takuya Mizukami, Matthaios Didagelos, Muhammad Aetesam-ur-Rahman, Peter McCartney, Carlos Collet, Tom Ford, Mitchell Lindsay, Paul Rocchiccioli, Richard Brogan, Stuart Watkins, Margaret McEntegart, Richard Good, Keith Robertson, Patrick O’Boyle, Andrew Davie, Adnan Khan, Stuart Hood, Hany Eteiba, Colin Berry, Keith Oldroyd
Publikováno v:
Journal of the American College of Cardiology. 80:B100-B101
Autor:
Martin R. Bennett, Nick E.J. West, Muhammad Aetesam-Ur-Rahman, Bobby Agrawal, Stephen P. Hoole, Catherine Jaworski, Adam J. Brown, Tian X. Zhao, Denise Braganza, Joel P. Giblett, Sarah C. Clarke
Publikováno v:
Journal of the American Heart Association. 10
Background Adenosine is used to treat no‐reflow in the infarct‐related artery (IRA) during ST‐segment–elevation myocardial infarction intervention. However, the physiological effect of adenosine in the IRA is variable. Coronary steal—a redu
Autor:
Thomas J. Ford, Stuart Watkins, Mitchell Lindsay, Richard Good, John D. McClure, Patrick O’Boyle, Colin Berry, Keith Robertson, Damien Collison, Paul Rocchiccioli, Samuel Copt, Adnan Khan, Peter McCartney, Hany Eteiba, Aadil Shaukat, Muhammad Aetesam-Ur-Rahman, Matthaios Didagelos, Stuart Hood, Margaret McEntegart, Keith G. Oldroyd, Andrew Davie, Richard Brogan, Robert McDade
Publikováno v:
European heart journal. 42(45)
Aims A fractional flow reserve (FFR) value ≥0.90 after percutaneous coronary intervention (PCI) is associated with a reduced risk of adverse cardiovascular events. TARGET-FFR is an investigator-initiated, single-centre, randomized controlled trial
Autor:
Saji Victor, Stephen P. Hoole, Tian X. Zhao, Sarah Fielding, Hafid Ait-Oufella, Muhammad Aetesam Ur-Rahman, Andrew P. Sage, Yi-Da Chiu, Mikel Mckie, Ziad Mallat, Rincy Kurian, Christoph J. Binder
Publikováno v:
Cardiovascular research. 118(3)
AIMS In pre-clinical models of acute myocardial infarction (MI), mature B cells mobilise inflammatory monocytes into the heart, leading to increased infarct size and deterioration of cardiac function, whilst anti-CD20 antibody mediated depletion of B